Levo Tinnitus System Receives Health Canada License as a Class 2 Medical Device

News provided by

Oct 16, 2014, 10:34 ET

PORTLAND, Ore., Oct. 16, 2014 /PRNewswire/ -- Otoharmonics® Corporation, announces that it has received a Class 2 medical device license from Health Canada for the Levo® system, a personalized neuroscience-based sound therapy for use in the temporary relief of tinnitus symptoms.

Leveraging the brain's natural cognitive abilities, Levo identifies and maps an individual's unique sound print using custom-fit ear buds and proprietary software on Apple iPad® and iPod® touch mobile digital devices.

The Levo System is designed to identify and map each individual's unique tinnitus sound print

Patients identify their unique tinnitus sound print using the Levo System

Often described as 'ringing in the ears', tinnitus is a result of false signaling in the brain due to inner ear cell damage. Most commonly caused by exposure to loud noise and/or hearing loss, it can have a profound impact on a person's quality of life.

According to the Tinnitus Association of Canada, more than 360,000 Canadians have severe tinnitus. About half of these are so debilitated by the condition that it impairs their quality of life. The American Tinnitus Association says some 50 million people in the United States experience tinnitus, with 2-3 million finding the condition debilitating, causing serious problems such as sleep loss, emotional distress and anxiety.

"Since announcing FDA 510(k) clearance last month, we've received many inquiries from Canadian patients and healthcare providers," says Michael Baker, Otoharmonics CEO. "We're very pleased to announce that the Levo tinnitus system is now available in Canada."

With their unique sound print identified and mapped, patients listen nightly to a customized therapy using the Levo System while sleeping. The ability to track progress over time and personalize therapy is embedded into the system.

To learn more about the Levo System visit www.otoharmonics.com

Otoharmonics Corporation is a privately held company with headquarters in Portland, Oregon USA. An international team of world–class neuroscientists, clinicians, business professionals and patients, Otoharmonics has developed the Levo System for the management of tinnitus symptoms. With a personal approach and a deep understanding of the impact tinnitus can have, Levo is designed to be user-friendly and capable of delivering custom sound therapy based on the specific needs of each individual.

Apple, iPod touch and iPad are registered trademarks of Apple Inc.

Media Inquiries: Brenda Edin, Email, 503.310.4417
Consumer Inquiries: [email protected]

Photo - http://photos.prnewswire.com/prnh/20141016/152554

Photo - http://photos.prnewswire.com/prnh/20141016/152547

SOURCE Otoharmonics Corporation